Cargando…
Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models
Alzheimer’s disease (AD) is characterised by amyloid-beta (Aβ) protein deposition in the brain. Posttranslational modifications in Aβ play an important role in Aβ deposition. Tissue transglutaminase (tTG) is an enzyme involved in posttranslational cross-linking of proteins. tTG levels and activity a...
Autores principales: | Wilhelmus, Micha M. M., de Jager, Mieke, Smit, August B., van der Loo, Rolinka J., Drukarch, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738336/ https://www.ncbi.nlm.nih.gov/pubmed/26837469 http://dx.doi.org/10.1038/srep20569 |
Ejemplares similares
-
Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022) -
The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease
por: Wilhelmus, Micha M. M., et al.
Publicado: (2022) -
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
por: Chrobok, Navina L., et al.
Publicado: (2016) -
Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions
por: Chrobok, Navina L, et al.
Publicado: (2019) -
Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
por: Chrobok, Navina L., et al.
Publicado: (2018)